PortfoliosLab logoPortfoliosLab logo
BOSC vs. CTMX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

BOSC vs. CTMX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in B.O.S. Better Online Solutions Ltd. (BOSC) and CytomX Therapeutics, Inc. (CTMX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, BOSC achieves a -6.58% return, which is significantly higher than CTMX's -25.82% return. Over the past 10 years, BOSC has outperformed CTMX with an annualized return of 1.64%, while CTMX has yielded a comparatively lower -11.61% annualized return.


BOSC

1D
3.65%
1M
-8.97%
YTD
-6.58%
6M
-3.07%
1Y
-9.75%
3Y*
10.94%
5Y*
3.37%
10Y*
1.64%

CTMX

1D
-8.41%
1M
-24.40%
YTD
-25.82%
6M
-17.06%
1Y
25.90%
3Y*
22.24%
5Y*
-14.21%
10Y*
-11.61%
*Multi-year figures are annualized to reflect compound growth (CAGR)

BOSC vs. CTMX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
BOSC
B.O.S. Better Online Solutions Ltd.
-6.58%38.18%25.00%26.44%-28.86%29.30%14.07%-8.29%-0.91%3.30%
CTMX
CytomX Therapeutics, Inc.
-25.82%313.59%-33.55%-3.13%-63.05%-33.89%-21.18%-44.97%-28.47%92.08%

Correlation

The correlation between BOSC and CTMX is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.08

Correlation (3Y)
Calculated over the trailing 3-year period

0.11

Correlation (5Y)
Calculated over the trailing 5-year period

0.09

Correlation (10Y)
Calculated over the trailing 10-year period

0.09

Correlation (All Time)
Calculated using the full available price history since Oct 9, 2015

0.10

Fundamentals

EPS

BOSC:

$0.83

CTMX:

-$0.37

PS Ratio

BOSC:

0.37

CTMX:

14.26

Total Revenue (TTM)

BOSC:

$50.57M

CTMX:

$35.54M

Gross Profit (TTM)

BOSC:

$12.08M

CTMX:

$24.77M

EBITDA (TTM)

BOSC:

$4.65M

CTMX:

-$62.07M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BOSC vs. CTMX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BOSC
BOSC Risk / Return Rank: 3232
Overall Rank
BOSC Sharpe Ratio Rank: 3131
Sharpe Ratio Rank
BOSC Sortino Ratio Rank: 2929
Sortino Ratio Rank
BOSC Omega Ratio Rank: 2929
Omega Ratio Rank
BOSC Calmar Ratio Rank: 3535
Calmar Ratio Rank
BOSC Martin Ratio Rank: 3636
Martin Ratio Rank

CTMX
CTMX Risk / Return Rank: 5252
Overall Rank
CTMX Sharpe Ratio Rank: 5050
Sharpe Ratio Rank
CTMX Sortino Ratio Rank: 5757
Sortino Ratio Rank
CTMX Omega Ratio Rank: 5656
Omega Ratio Rank
CTMX Calmar Ratio Rank: 4949
Calmar Ratio Rank
CTMX Martin Ratio Rank: 5050
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BOSC vs. CTMX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for B.O.S. Better Online Solutions Ltd. (BOSC) and CytomX Therapeutics, Inc. (CTMX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


BOSCCTMXDifference

Sharpe ratio

Return per unit of total volatility

-0.22

0.27

-0.49

Sortino ratio

Return per unit of downside risk

-0.01

1.17

-1.18

Omega ratio

Gain probability vs. loss probability

1.00

1.15

-0.15

Calmar ratio

Return relative to maximum drawdown

-0.15

0.36

-0.51

Martin ratio

Return relative to average drawdown

-0.26

0.82

-1.08

BOSC vs. CTMX - Sharpe Ratio Comparison

The current BOSC Sharpe Ratio is -0.22, which is lower than the CTMX Sharpe Ratio of 0.27. The chart below compares the historical Sharpe Ratios of BOSC and CTMX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


BOSCCTMXDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.22

0.27

-0.49

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.07

-0.10

+0.17

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.03

-0.10

+0.14

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.14

-0.11

-0.02

Drawdowns

BOSC vs. CTMX - Drawdown Comparison

The maximum BOSC drawdown since its inception was -99.90%, roughly equal to the maximum CTMX drawdown of -98.74%. Use the drawdown chart below to compare losses from any high point for BOSC and CTMX.


Loading charts...

Drawdown Indicators


BOSCCTMXDifference

Max Drawdown

Largest peak-to-trough decline

-99.90%

-98.74%

-1.16%

Max Drawdown (1Y)

Largest decline over 1 year

-37.73%

-53.19%

+15.46%

Max Drawdown (3Y)

Largest decline over 3 years

-39.13%

-91.59%

+52.46%

Max Drawdown (5Y)

Largest decline over 5 years

-59.35%

-94.16%

+34.81%

Max Drawdown (10Y)

Largest decline over 10 years

-64.34%

-98.74%

+34.40%

Current Drawdown

Current decline from peak

-99.70%

-90.77%

-8.93%

Average Drawdown

Average peak-to-trough decline

-89.50%

-70.68%

-18.82%

Ulcer Index

Depth and duration of drawdowns from previous peaks

21.95%

23.48%

-1.53%

Volatility

BOSC vs. CTMX - Volatility Comparison

B.O.S. Better Online Solutions Ltd. (BOSC) has a higher volatility of 14.77% compared to CytomX Therapeutics, Inc. (CTMX) at 13.47%. This indicates that BOSC's price experiences larger fluctuations and is considered to be riskier than CTMX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


BOSCCTMXDifference

Volatility (1M)

Calculated over the trailing 1-month period

14.77%

13.47%

+1.30%

Volatility (6M)

Calculated over the trailing 6-month period

30.09%

68.39%

-38.30%

Volatility (1Y)

Calculated over the trailing 1-year period

44.75%

96.84%

-52.09%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

48.22%

141.79%

-93.57%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

52.26%

111.38%

-59.12%

Dividends

BOSC vs. CTMX - Dividend Comparison

Neither BOSC nor CTMX has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

BOSC vs. CTMX - Financials Comparison

This section allows you to compare key financial metrics between B.O.S. Better Online Solutions Ltd. and CytomX Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0010.00M20.00M30.00M40.00M50.00M20222023202420252026
12.62M
10.26M
(BOSC) Total Revenue
(CTMX) Total Revenue
Values in USD except per share items

Frequently Asked Questions


BOSC and CTMX have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BOSC has higher volatility (14.77%) compared to CTMX (13.47%). In terms of maximum drawdown, BOSC dropped -99.90% vs CTMX's -98.74%.

CTMX currently has the higher Sharpe Ratio (0.27 vs -0.22), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for BOSC and CTMX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer